Assuntos
Compostos de Anilina/farmacologia , Doenças do Colágeno/induzido quimicamente , Resinas Epóxi/intoxicação , Doenças Profissionais/induzido quimicamente , Poliaminas/intoxicação , Polietilenos/intoxicação , Tritolil Fosfatos/intoxicação , Adulto , Doenças do Colágeno/diagnóstico , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/diagnóstico , Intoxicação/diagnóstico , Intoxicação/etiologia , SíndromeRESUMO
Results are reported of trypsin treatment of 150 patients with herpetic infection (age of the patients: from 7 to 65 years). The results were compared with routine treatment in 200 patients. High efficacy of trypsin treatment as compared with routine treatment methods has been revealed. Trypsin treatment results in control of the pathological signs and symptoms not only in the acute period but also resulted in absence of recurrences of the infection and postherpetic neuralgia for 3 successive years. The efficacy of trypsin treatment has been thus established and the necessity of active detection and treatment of chronic carriers of herpetic infection by the proposed method is advocated.
Assuntos
Herpes Simples/tratamento farmacológico , Herpes Zoster/tratamento farmacológico , Tripsina/uso terapêutico , Adolescente , Adulto , Idoso , Criança , Avaliação de Medicamentos , Humanos , Pessoa de Meia-IdadeAssuntos
Ectromelia/diagnóstico , Micrognatismo/diagnóstico , Microftalmia/diagnóstico , Feminino , Humanos , Lactente , SíndromeRESUMO
Immunoenzymatic, clinical and follow up study of 3500 patients suffering from nervous forms of epidemic parotitis was performed. It is concluded that the adaptive humoral enzymes, ribonuclease and trypsin, the persistence of antigen to epidemic parotitis virus in CSF lymphocytes as well as the immunologic status of the patient at the disease onset play the leading role in the pathogenesis of its acute phase. It advisable to examine the factors enumerated in order to predict the clinical course of the disease. The treatment with adaptive enzymes was of great efficacy in 660 patients.
Assuntos
Meningite/etiologia , Meningoencefalite/etiologia , Caxumba/complicações , Mielite/etiologia , Criança , Pré-Escolar , Humanos , Masculino , Meningite/terapia , Meningoencefalite/terapia , Caxumba/terapia , Prognóstico , Ribonucleases/uso terapêutico , Tripsina/uso terapêuticoAssuntos
Interferon Tipo I/uso terapêutico , Meningite Viral/terapia , Caxumba/terapia , Adolescente , Criança , Pré-Escolar , Seguimentos , HumanosAssuntos
Doenças Autoimunes/sangue , Leucócitos/imunologia , Meningite Viral/imunologia , Meningoencefalite/imunologia , Caxumba/imunologia , Adolescente , Criança , Pré-Escolar , Humanos , Hipersensibilidade Tardia/imunologia , Masculino , Meningite Viral/sangue , Meningoencefalite/sangue , Caxumba/sangueAssuntos
Caxumba/tratamento farmacológico , Doenças do Sistema Nervoso/tratamento farmacológico , Tripsina/uso terapêutico , Adolescente , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/imunologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Caxumba/complicações , Caxumba/imunologia , Doenças do Sistema Nervoso/etiologia , Doenças do Sistema Nervoso/imunologiaAssuntos
Doenças do Sistema Nervoso/tratamento farmacológico , Viroses/tratamento farmacológico , Animais , Antibacterianos/uso terapêutico , Antivirais/uso terapêutico , Ensaios Clínicos como Assunto , Desoxirribonucleases/uso terapêutico , Humanos , Indutores de Interferon/uso terapêutico , Interferons/uso terapêutico , Ribonucleases/uso terapêutico , Vacinas Virais/uso terapêutico , Replicação ViralRESUMO
The authors studied antibodies to the nervous tissue in the blood (pair serum with an interval of 10 days) and in the CSF in 155 patients with epidemic parotitis and signs of neurotoxicosis, parotit meningitis and meningoencephalitis. Depending upon the intensivity of antibody elaboration 3 groups were distinguished. The first group (40 cases), with a high content of antibodies to the nervous tissue, was characterized by a prevalence of encephalitic forms (in 30 of the 40 cases). In the second group (32 cases) with a less antibody content there was a prevalence of meningitis, while meningoencephalitis was seen only in 3 cases. The third group (83 cases) with a low concentration or absence of antibodies was characterized by a mild course of the disease. This group included as well patients with neurotoxicosis. These data may indicate involvement of allergic mechanisms of a retarded type in the pathogenesis of remote lesions of the nervous system in epidemic parotitis.